Literature DB >> 25835421

The Synergistic Relationship between Alzheimer's Disease and Sleep Disorders: An Update.

Chiara Villa1, Luigi Ferini-Strambi2, Romina Combi1.   

Abstract

Sleep disorders are frequently reported in Alzheimer's disease (AD), with a significant impact on patients and caregivers and a major risk factor for early institutionalization. Although changes in sleep organization are a hallmark of the normal aging processes, sleep macro- and micro-architectural alterations are more evident in patients affected by AD. Degeneration of neural pathways regulating sleep-wake patterns and sleep architecture may contribute to sleep alterations. In return, several recent studies suggested that common sleep disorders may precede clinical symptoms of dementia and represent risk factors for cognitive decline, through impairment of sleep-dependent memory consolidation processes. Thus, a close relationship between sleep disorders and AD has been largely hypothesized. Here, sleep alterations in AD and its pre-dementia stage, mild cognitive impairment, and their complex interactions are reviewed.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-β; mild cognitive impairment; sleep disorders

Mesh:

Year:  2015        PMID: 25835421     DOI: 10.3233/JAD-150138

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  11 in total

Review 1.  Sleep Disturbances in Frontotemporal Dementia.

Authors:  Stuart J McCarter; Erik K St Louis; Bradley F Boeve
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

2.  Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.

Authors:  Wei Zhang; Xue-Yan Chen; Su-Wen Su; Qing-Zhong Jia; Tao Ding; Zhong-Ning Zhu; Tong Zhang
Journal:  Neurol Sci       Date:  2015-08-09       Impact factor: 3.307

Review 3.  Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.

Authors:  Lynn Marie Trotti; Elias G Karroum
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

4.  Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.

Authors:  Min Kim; Stuart Snowden; Tommi Suvitaival; Ashfaq Ali; David J Merkler; Tahmina Ahmad; Sarah Westwood; Alison Baird; Petroula Proitsi; Alejo Nevado-Holgado; Abdul Hye; Isabelle Bos; Stephanie Vos; Rik Vandenberghe; Charlotte Teunissen; Mara Ten Kate; Philip Scheltens; Silvy Gabel; Karen Meersmans; Olivier Blin; Jill Richardson; Ellen De Roeck; Kristel Sleegers; Régis Bordet; Lorena Rami; Petronella Kettunen; Magda Tsolaki; Frans Verhey; Isabel Sala; Alberto Lléo; Gwendoline Peyratout; Mikel Tainta; Peter Johannsen; Yvonne Freund-Levi; Lutz Frölich; Valerija Dobricic; Sebastiaan Engelborghs; Giovanni B Frisoni; José L Molinuevo; Anders Wallin; Julius Popp; Pablo Martinez-Lage; Lars Bertram; Frederik Barkhof; Nicholas Ashton; Kaj Blennow; Henrik Zetterberg; Johannes Streffer; Pieter J Visser; Simon Lovestone; Cristina Legido-Quigley
Journal:  Alzheimers Dement       Date:  2019-05-08       Impact factor: 21.566

5.  Biomarkers for Alzheimer's Disease: Where Do We Stand and Where Are We Going?

Authors:  Chiara Villa
Journal:  J Pers Med       Date:  2020-11-20

Review 6.  Zinc in Cognitive Impairment and Aging.

Authors:  Ruize Sun; Jue Wang; Juan Feng; Bin Cao
Journal:  Biomolecules       Date:  2022-07-18

Review 7.  Research advances in the study of sleep disorders, circadian rhythm disturbances and Alzheimer's disease.

Authors:  Xiangyang Xiong; Tianpeng Hu; Zhenyu Yin; Yaodan Zhang; Fanglian Chen; Ping Lei
Journal:  Front Aging Neurosci       Date:  2022-08-17       Impact factor: 5.702

Review 8.  A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment.

Authors:  Meghan K Mattos; Angela Chang; Katherine Pitcher; Carley Whitt; Lee M Ritterband; Mark S Quigg
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

Review 9.  Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies.

Authors:  Elena Urrestarazu; Jorge Iriarte
Journal:  Nat Sci Sleep       Date:  2016-01-14

Review 10.  Can SARS-CoV-2 Infection Exacerbate Alzheimer's Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms.

Authors:  Chiara Villa; Eleonora Rivellini; Marialuisa Lavitrano; Romina Combi
Journal:  J Pers Med       Date:  2022-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.